Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER_GOV × Adalimumab × Clear all

Phase

Status

Sponsor Class

OTHER 15 INDUSTRY 15 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Colitis, Ulcerative 1

Interventions

Gemcitabine 15 Cisplatin 12 Radiotherapy 11 Metformin 8 Paclitaxel 7 Fluorouracil 7 Exercise 7 Capecitabine 7 Oxaliplatin 6 Indocyanine Green 6 Docetaxel 6 Cyclophosphamide 6 Control Groups 6 Surveys and Questionnaires 5 Standard of Care 5 Nivolumab 5 Letrozole 5 Irinotecan 5 pembrolizumab 4 Zoledronic Acid 4 Vinorelbine 4 Saline Solution 4 Preoperative Exercise 4 Magnetic Resonance Spectroscopy 4 Ifosfamide 4 Gefitinib 4 Drug Therapy 4 Carboplatin 4 durvalumab 3 Trastuzumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03011268 2025-05-31

BIOSTOP

Helse Møre og Romsdal HF

Phase NA Completed

Colitis, Ulcerative, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡